secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker FLGT CIK 0001674930
other material confidence high sentiment neutral materiality 0.10

Fulgent Genetics announces 2024 annual meeting voting results

Fulgent Genetics, Inc.

item 5.07

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0000950170-24-061120
form_type
8-K
ticker
FLGT
cik
0001674930
company_name
Fulgent Genetics, Inc.
filed_at
2024-05-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:19.530381+00:00
generated_at
2026-06-01T21:21:16.574358+00:00
sec_items
["5.07"]
event_type
other_material
sentiment
neutral
materiality_score
0.1
calibrated_materiality_score
0.1
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0000950170-24-061120
json_url
https://secwatch.observer/filing/0000950170-24-061120.json
markdown_url
https://secwatch.observer/filing/0000950170-24-061120.md
text_url
https://secwatch.observer/filing/0000950170-24-061120.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1674930/000095017024061120/0000950170-24-061120-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1674930/000095017024061120/flgt-20240516.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

3ecb177bda0e6c216ac42e7366fc1a740a734850

Fulgent Genetics, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-16 meeting.

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

cbe397195d7c8c12c40e9bed9cd541486a77623c

Fulgent Genetics, Inc. shareholders approved Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers at the 2024-05-16 meeting.

Proposal 3 Approval, on a non-binding advisory basis, the compensation of the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Vote 19,786,239 573,411 25,950 4,095,268

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

e747ff9b266d931532ddff2464826880a2a5caeb

Fulgent Genetics, Inc. shareholders approved Election of directors at the 2024-05-16 meeting.

Proposal 1 Election of the following nominees as directors of the Company, each to serve until the 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified. Votes For Votes Withheld Broker Non-Vote Ming Hsieh 20,071,185 314,415 4,095,268 Michael Nohaile, Ph.D. 17,462,830 2,922,770 4,095,268 Regina Groves 17,487,701 2,897,899 4,095,268 Linda Marsh 15,854,682 4,530,918 4,095,268

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

Comparable filings

DUOT

Duos Tech annual meeting: all five director nominees elected, auditor ratified

DUOS TECHNOLOGIES GROUP, INC. June 2, 2026, 8:30 AM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

Proposal No. 4 : To elect Frank D. Recker, Chief Executive Officer of the Company, to serve as a member of the board of directors and to hold office for a one-year term and until his successor is elected and qualified. Votes For Votes With held Frank D. Recker 13,959,958 2,064,009

Filing page SEC filing

SRTS

Sensus Healthcare shareholders re-elect directors, approve advisory vote on pay, ratify auditor

Sensus Healthcare, Inc. June 2, 2026, 8:26 AM ET other_material Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

Election of Directors . Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term to expire in 2029. Each nominee was an incumbent director, and no other person was nominated. The tabulation of votes cast was as follows: For Against Abstention Broker Non-Votes Eric Sachetta 5,532,247 516,567 270,440 5,000,719

Filing page SEC filing

MPT

MPT shareholders elect all directors, approve say-on-pay and equity plan with notable opposition

MEDICAL PROPERTIES TRUST INC June 1, 2026, 4:55 PM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

Proposal 2: The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026: For: Against: Abstensions: Broker Non-Votes: 459,883,831 6,189,396 2,613,330 —

Filing page SEC filing

VOYG

Stockholders approve redomestication from Delaware to Texas at annual meeting

Voyager Technologies, Inc./DE June 1, 2026, 4:49 PM ET other_material Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

The results of the vote were as follows: For Against Abstain Broker Non-Votes 98,600,810 8,426,781 98,301 13,043,864 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Filing page SEC filing

TDAY

Annual meeting elects directors, ratifies auditor; four governance proposals fail to meet 80% supermajority threshold

USA TODAY Co., Inc. June 1, 2026, 4:31 PM ET other_material Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

Proposal 1 . The Company's stockholders elected the following eight director nominees to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified.

Filing page SEC filing

NSTS

NSTS Bancorp annual meeting: directors elected, auditor ratified

NSTS Bancorp, Inc. June 1, 2026, 4:16 PM ET other_material Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

The ratification of the appointment of Plante & Moran, PLLC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026: FOR AGAINST ABSTAIN BROKER NON-VOTES 3,708,805 207,145 85,662 0

Filing page SEC filing

LODE

Comstock holds AGM; all director nominees elected, auditor and equity plan approved

Comstock Inc. June 1, 2026, 4:15 PM ET other_material Items 5.07, 7.01, 9.01

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

4. Vote on Comstock Inc. 2026 Equity Incentive Plan. The stockholders approved the Comstock Inc. 2026 Equity Incentive Plan as set forth below. Voted For Voted Against Abstain Broker Non-Votes 25,069,375 1,393,479 1,194,028 21,410,649

Filing page SEC filing

CBNK

Capital Bancorp shareholders elect all director nominees, approve say-on-pay, ratify auditor

Capital Bancorp Inc June 1, 2026, 4:05 PM ET other_material Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other_material similar materiality

This filing

Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —

Comparable filing

Proposal 3 – The ratification of the appointment of Elliott Davis, PLLC as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026. FOR AGAINST ABSTAIN BROKER NON-VOTES 13,466,844 198,796 9,223 0

Filing page SEC filing

Source: SEC EDGAR
accession 0000950170-24-061120
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.